Aragen Announce Multi-Year Partnership With FMC Corporation, Aims at Accelerating Agro-Chemical Pipeline
15.6.2021 10:03:00 EEST | Business Wire | Press release
Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), head quartered out of Hyderabad, India, announced a strategic partnership with FMC Corporation, a global leader in innovative agricultural science, that provides solutions towards crop protection, plant health, and professional pest and turf management. Through this collaboration, Aragen will support FMC’s global discovery and development needs, including discovery chemistry, discovery biology, and chemical process development.
This partnership is focused on accelerating FMC Corporation’s agro-chemical pipeline. “It has been our privilege to have been able to assist FMC, one of the global leaders in crop science, accelerate its R&D, through this long term partnership. The expansion of this collaboration through all facets of discovery and development is a testimony to the trust and confidence that FMC has in Aragen - we look forward to driving several more success stories for our partner,” said Manni Kantipudi, CEO of Aragen.
Kathleen Shelton, Chief Technology Officer Research and Development at FMC Corporation, on talking about the partnership agreement said, “Aragen has been a valued collaborator of FMC for several years,” said Dr. Kathleen Shelton, Vice President and Chief Technology Officer at FMC. “This partnership extends across multiple disciplines in research and development and we appreciate our strong working relationship.”
About Aragen Life Sciences
Aragen Life Sciences Pvt Ltd (Aragen) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms. With a team of over 3100 professionals, and through a network of sites around the world, we offer a seamless, integrated platform to advance customer programs from discovery through commercialization for both small molecules and biologics. Established in 2001, Aragen now serves over 450 customers worldwide across multiple modalities and therapeutic areas.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005505/en/
Contact information
Aragen Life Sciences: Sarat Patanaik, +91 95732 80064, sarat.patanaik@aragen.com
MediaMedic Communications Pvt.Ltd.: Bhavna Pathak, +918830654608, info@mediamedichealth.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sagepath Reply Recognized in the 2026 Gartner® Market Guide for Strategic Website Agencies21.7.2026 11:00:00 EEST | Press release
Sagepath Reply, a digital experience agency part of the Reply Group, has been included in the 2026 Gartner Market Guide for Strategic Website Agencies. This marks the third time Sagepath Reply has been named in the Market Guide, following its previous inclusions in 2023 and 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721481392/en/ Sagepath Reply, a digital experience agency part of the Reply Group, has been included in the 2026 Gartner Market Guide for Strategic Website Agencies. Gartner, a company delivering actionable, objective insight to executives and their teams, defines strategic website agencies as “service providers dedicated to developing website strategies that deliver relevant digital experiences to external audiences. These agencies bundle their strategic marketing services with an array of complementary offerings to support their clients’ needs around website design, development, search value and co
ClickHouse Announced as Principal Partner & Front of Shirt Sponsor of Fulham Football Club21.7.2026 11:00:00 EEST | Press release
Fulham Football Club is proud to announce ClickHouse, a global technology company specialising in real-time analytics, data infrastructure and AI applications, as its newest Principal Partner and Front of Shirt Sponsor of the Men’s First Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721902779/en/ ClickHouse announced as Principal Partner and Front of Shirt Sponsor of Fulham Football Club This multi-year partnership will see ClickHouse take pride of place on the front of the Men’s First Team home, away and third kits. ClickHouse will also feature across Craven Cottage, the Club’s digital channels, matchday assets and a range of supporter-facing experiences throughout the partnership. The Fulham FC home kit will be released on Thursday 23rd July 2026, keep an eye on the Club’s Instagram for updates. Our collaboration reflects Fulham’s continued focus on innovation, performance and delivering engaging experiences for
European Commission Approves Crysvita ® (burosumab) for Infants with X-linked Hypophosphataemia in the European Union21.7.2026 10:00:00 EEST | Press release
Kyowa Kirin EMEA, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151), today announced that the European Commission (EC) has approved an expansion of the indication for Crysvita® (burosumab) for the treatment of X-linked hypophosphataemia (XLH), to include infants from 1 month to 1 year of age across the European Union and European Economic Area. The approval represents an important step forward for infants living with XLH, a rare, progressive genetic disease that can affect skeletal development from an early age. Earlier diagnosis and treatment are considered important in XLH given the potential impact of the disease on skeletal development during infancy and childhood. XLH is a rare, progressive, lifelong genetic disease characterised by phosphate wasting that can impair bone mineralisation from an early age, leading to skeletal deformities, impaired growth and other serious complications. Clinical manifestations of XLH can emerge during infancy and early childhood, with pr
CapVest Completes Acquisition of TSG21.7.2026 10:00:00 EEST | Press release
CapVest Partners LLP (“CapVest”), a leading New York and London based investment firm, today announces that it has completed its acquisition of a majority stake in TSG Solutions (“TSG”), a European leader in technical services for critical energy infrastructure, following receipt of all necessary approvals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721628079/en/ TSG Headquartered in Paris, France, TSG operates across 30 countries with over 7,000 employees and annual revenues of more than €1.4 billion. The company designs, builds and maintains critical energy infrastructure across Power (HV, MV & LV electrical), Charge, Solar, Battery Energy Storage Systems (BESS), Biofuels and Gas & Biogas. TSG’s multi-energy capabilities, deep technical expertise and extensive geographical coverage underpin longstanding relationships with a diverse base of leading energy infrastructure operators, and position the company to capture
Ant International Raises approx. US$1.2 billion in Series A Equity Financing to Boost Cross-border Payments, Agentic Commerce Solutions for Global Businesses21.7.2026 06:00:00 EEST | Press release
Ant International, a leading global digital payment, digitisation and financial technology provider, today announced the successful closing of its Series A equity financing of approximately US$1.2 billion. Existing investors including Ant Group and Alibaba Group participated in this round, as well as other renowned international investment institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260720424592/en/ Ant International today announced the successful closing of its Series A equity financing of approximately US$1.2 billion. The proceeds will be used to accelerate Ant International’s global expansion and innovation in merchant payment, account management and other inclusive financial services for SMEs and enterprises across the world. Ant International began independent operation in 2024. With main operations across Asia, Europe, the Middle East and Latin America, the company has built an expansive partnership ne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom